ACL TOP 700; PN 0000280010 Bench top, fully automated, random access analyzer designed specifically for in vitro diagnostic clinical use in the hemostasis laboratory for coagulation and/or fibrinolysis testing in the assessment of thrombosis and/or hemostasis. The systems provide results for both direct hemostasis measurements and calculated parameters.
Published September 25, 2013 · Recall initiated: July 19, 2013
Summary
FDA records medical device Class II recall Z-2245-2013, published September 25, 2013 and initiated July 19, 2013. Recalling firm: Instrumentation Laboratory Co.; Status: Terminated; Reported quantity: 311; Lot: Start SN and Date: 09080100, Aug 2009 End SN and Date: 13070559, July 2013. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Potential carryover issue that can can cause shortened APTT clotting times on the instrument.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Instrumentation Laboratory Co.
- Distributor
- Worldwide Distribution - USA including AL, AR, AZ, CA, CO, CT, DE, FL, GA, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NV, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VA, VT, WA, WI, and WV. Internationally to Canada, Argentina, Australia, Austria, Belarus, Belgium, Brazil, Brunei, Chile, China, Colombia, Costa Rica, Czech Republic, Denmark, Dubai, Finland, France, Germany, Great Britian, Greece, Guatemala, Hong Kong, Hungary, India, Ireland, Israel, Italy, Japan, Korea, Kuwait, Luthuania, Luxembourg, Malaysia, Mexico, Netherlands, New Zealand, Norway, Panama, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Serbia, Singapore, Slovakia, Slovenia, South Africa, Spain, Sweden, Switzerland, Taiwan, Thailand, Tunisia, Turkey, Uruguay, Venezuela, and Viet Nam.
- Lot
- Start SN and Date: 09080100, Aug 2009 End SN and Date: 13070559, July 2013
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDAROTEM ex-tem Canada Part No: 503-05-CASeptember 18, 2019
- FDAROTEM ex-tem Rest of the world part No: 503-05 (ROW)September 18, 2019
- FDAHemosIL Plasminogen, Part No. 0020009000, IVD. Instrumentation Laboratory Company. Kit contents: 2 x 2.5 mLFebruary 10, 2016
- FDAHemosIL PT-Fibrinogen HS PLUS, IVD --- Instrumentation Laboratory IL Company. A high sensitivityDecember 31, 2014
- FDAACL TOP (Base); PN 0000280000 Bench top, fully automated, random access analyzer designed specifically for inSeptember 25, 2013
- FDAACL TOP CTS; PN 0000280020 Bench top, fully automated, random access analyzer designed specifically for inSeptember 25, 2013
Questions about this recall
Was ACL TOP 700; PN 0000280010 Bench top, fully automated, random access analyzer designed specifically for in vitro diagnostic clinical use in the hemostasis laboratory for coagulation and/or fibrinolysis testing in the assessment of thrombosis and/or hemostasis. The systems provide results for both direct hemostasis measurements and calculated parameters. recalled?
Yes. FDA published recall Z-2245-2013 on September 25, 2013. Reported hazard: Potential carryover issue that can can cause shortened APTT clotting times on the instrument.
What should I do if I have this product?
Voluntary: Firm initiated · Letter